GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
• https://www.reuters.com, By Brendan PiersonGSK (GSK.L), opens new tab has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
